Is Succinic semialdehyde dehydrogenase deficiency contagious?

Succinic semialdehyde dehydrogenase deficiency is a rare metabolic disorder and is absolutely not contagious. It is a genetic condition caused by an inherited mutation, meaning it cannot be spread through physical contact, air, water, or any other form of transmission between people.

Is Succinic semialdehyde dehydrogenase deficiency contagious?

No, Succinic semialdehyde dehydrogenase deficiency cannot be caught, transmitted, or passed from one person to another. Because it is a strictly genetic, autosomal recessive metabolic condition, it is physically impossible for a caregiver, family member, or friend to "contract" it. There is no risk associated with living with, touching, or caring for someone with Succinic semialdehyde dehydrogenase deficiency. You cannot transmit this condition through saliva, blood, or daily social interaction.

What causes Succinic semialdehyde dehydrogenase deficiency?

Succinic semialdehyde dehydrogenase deficiency is caused by mutations in the ALDH5A1 gene. This gene provides instructions for producing the enzyme succinic semialdehyde dehydrogenase, which is responsible for breaking down a neurotransmitter called gamma-aminobutyric acid (GABA). When this enzyme is deficient, GABA and other toxic metabolites accumulate in the brain, leading to the neurological symptoms associated with the condition. Because it is an autosomal recessive disorder, an affected individual must inherit one mutated copy of the gene from each parent, who are typically asymptomatic carriers.

Why do misconceptions about contagion exist?

The stigma surrounding rare metabolic disorders often stems from a lack of public awareness. Because Succinic semialdehyde dehydrogenase deficiency can present with developmental delays, intellectual disability, or motor impairment, those unfamiliar with the condition may mistakenly assume the symptoms are caused by an infection or a communicable illness. It is important to emphasize that these symptoms are purely the result of internal metabolic pathways and genetic inheritance. There are no environmental triggers—such as bacteria or viruses—that can cause or worsen this condition in others.

How does the condition impact daily life?

Living with Succinic semialdehyde dehydrogenase deficiency requires specialized medical management rather than isolation. Patients and their families often navigate a complex healthcare journey, and our DiseaseMaps.org community currently includes 13 members who share their experiences and support one another in managing the daily realities of this rare disease. The following factors are central to understanding the condition:

• Genetics: It is an autosomal recessive trait, meaning there is a 25% chance of recurrence in future pregnancies if both parents are carriers.


• Clinical Presentation: Symptoms often begin in infancy or early childhood, commonly including hypotonia (low muscle tone), delayed speech, and sometimes seizures.


• Metabolic Impact: The accumulation of 4-hydroxybutyric acid (GHB) in the brain is the primary marker used for diagnosis, typically confirmed via urine organic acid analysis.


• Safety: There is zero risk of transmission to siblings, classmates, or medical staff.

Next steps

• Consult with a metabolic geneticist or a pediatric neurologist to discuss individualized care plans.


• Connect with the 13 members in the DiseaseMaps.org community to share experiences and reduce feelings of isolation.


• Visit the NIH Genetic and Rare Diseases Information Center (GARD) website for the most current clinical research updates.


• Reach out to organizations like the SSADH Association to find specialized support and resources for families.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Succinic semialdehyde dehydrogenase deficiency overview.


• Orphanet: Succinic semialdehyde dehydrogenase deficiency (ORPHA:3197).


• OMIM (Online Mendelian Inheritance in Man): Entry #271980 (Succinic semialdehyde dehydrogenase deficiency).


• SSADH Association: Official patient support and research advocacy organization.